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Trained immunity defines long-lasting adaptations of innate
immunity based on transcriptional and epigenetic modifications of
myeloid cells and their bone marrow progenitors [M. Divangahi et
al., Nat. Immunol. 22, 2–6 (2021)]. Innate immune cells, however,
do not exclusively differentiate between foreign and self but
also react to host-derived molecules referred to as alarmins. Extra-
cellular “labile” heme, released during infections, is a bona fide
alarmin promoting myeloid cell activation [M. P. Soares, M. T.
Bozza, Curr. Opin. Immunol. 38, 94–100 (2016)]. Here, we report
that labile heme is a previously unrecognized inducer of trained
immunity that confers long-term regulation of lineage specifica-
tion of hematopoietic stem cells and progenitor cells. In contrast
to previous reports on trained immunity, essentially mediated by
pathogen-associated molecular patterns, heme training depends
on spleen tyrosine kinase signal transduction pathway acting
upstream of c-Jun N-terminal kinases. Heme training pro-
motes resistance to sepsis, is associated with the expansion of
self-renewing hematopoetic stem cells primed toward myelopoie-
sis and to the occurrence of a specific myeloid cell population. This
is potentially evoked by sustained activity of Nfix, Runx1, and
Nfe2l2 and dissociation of the transcriptional repressor Bach2. Pre-
viously reported trained immunity inducers are, however, infre-
quently present in the host, whereas heme abundantly occurs
during noninfectious and infectious disease. This difference might
explain the vanishing protection exerted by heme training in sep-
sis over time with sustained long-term myeloid adaptations.
Hence, we propose that trained immunity is an integral compo-
nent of innate immunity with distinct functional differences on
infectious disease outcome depending on its induction by patho-
genic or endogenous molecules.
heme j trained innate immunity j myelopoiesis j single-nuclei analysis j
sepsis
The tetrapyrrole heme acts as the prosthetic group of vitalhemoproteins such as hemoglobin (1). Following hemolysis
or tissue damage, cell-free, “labile” heme can accumulate in
plasma (2, 3) and, if not contained, promotes free radical pro-
duction in an unfettered manner contributing critically to the
pathogenesis of severe acute infectious disease as demonstrated
for malaria (4) and for bacterial sepsis (5–7). Heme also trig-
gers an inflammatory response, especially on macrophages
(Mϕ) through pattern-recognition receptors (PRRs) (8, 9).
Hence, heme is perceived as a prototypical damage-associated
molecular pattern (DAMP) (10, 11) or alarmin (6).
PRRs mainly evolved to recognize pathogen-associated
molecular patterns (PAMPs) expressed by microbes (12).
Depending on the origin of the PAMP, PRR-mediated signaling
can lead to persistently modulated reactions to subsequent
inflammatory cues which manifests as enhanced or dampened
ensuing responses. Such responses are referred to as trained immu-
nity if enhanced and as tolerance if dampened (13–16). It is now
well established that these long-lasting effects are enabled by
specific histone modifications and the expansion of hematopoi-
etic stem and progenitor cells (HSPCs) in vivo and that this can
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confer an improved host resistance to infection (15, 17–20).
Trained immunity is perceived as part of an evolutionarily con-
served host defense strategy, acting in a protective manner
against different pathogens (13, 20, 21). A similar phenomenon
is observed with the sickle cell trait protecting against malaria,
which is mediated by chronic and low-dose cellular exposure to
“labile” heme exerting protective effects via the induction of
the catabolizing enzyme heme oxygenase-1 (HO-1) (22). We
here asked whether heme induces long-lasting rewiring of
innate immune responses, reminiscent of trained immunity to
enhance host resistance to infection.
Results
Heme Induces Trained Immunity. Given the importance of
heme for noninfectious and infectious disease, we hypothesized
that labile heme might induce innate immune cell training
beyond its short-term immunomodulatory properties (9, 23).
We first used a well-established in vitro two-hit monocyte-to-
macrophage model of trained immunity (Fig. 1A) and
assessed whether heme exposure elicits innate immune cell
memory, similarly to the established inducer β-glucan (24).
Heme was applied to purified primary human monocytes for
24 h at a concentration of 50 μM, a level which can be
detected in plasma during severe acute infections (5). After 6
d, the resulting macrophages (Mφ) were exposed to lipopoly-
saccharide (LPS; 10 ng/mL) as a secondary stimulus. This
resulted in increased tumor necrosis factor (TNF) release as
compared to nontrained controls, characteristic for trained
immunity (Fig. 1B and SI Appendix, Fig. S1A). No remaining
heme nor cytokines were detected in the supernatants of the
trained cells before restimulation, supporting the notion that
cells had returned to steady state prior to secondary chal-
lenge, which is consistent with the definition of trained immu-
nity (SI Appendix, Fig. S1 B and C). Having established that
heme indeed induces a trained immunity phenotype based on
TNF secretion, we further characterized the immune response
by measuring different cytokines in the supernatant (SI
Appendix, Fig. S1D). The first stimulation with LPS or applica-
tion of different DAMPs, such as ATP, failed to increase TNF
release in response to LPS secondary challenge (SI Appendix,
Fig. S1 E and F). Of note, replacing the secondary stimulus
with the TLR1/2 agonist Pam3CSK4 resulted in comparable
TNF release as observed with LPS (Fig. 1C). This suggests
that labile heme induces a distinct signaling cascade that pro-
motes innate immune training.
While most of the described biological effects described for
heme are linked to its pro-oxidative properties exerted by the
central iron atom (1), this appears not to be the case for heme-
induced trained immunity. Pre-exposure to protoporphyrin IX
(PPIX), which structurally resembles heme but lacks iron,
equally increased TNF secretion from human Mφ in response
to LPS secondary challenge (SI Appendix, Fig. S1G). Also,
several other, but not all, porphyrins could induce trained
immunity (SI Appendix, Fig. S1H). In support of this notion,
administration of the antioxidant N-Acetyl Cysteine (NAC) did
not abolish heme-induced training, despite increased produc-
tion of reactive oxygen species during induction of trained
immunity (SI Appendix, Fig. S1 I–K).
On a molecular level, trained immunity involves histone
modifications, most prominently histone 3 lysine 27 acetylation
(H3K27ac), and consequently transcriptional alterations (13,
18–20). To confirm whether protein acetylation is involved
in the phenotype induced by heme, we applied the unspecific
acetylase inhibitor epigallocatechin-3-gallate (EGCG) during
heme treatment. This prevented the enhanced TNF release
observed after LPS stimulation (SI Appendix, Fig. S1I). Chro-
matin immunoprecipitation sequencing (ChIP-seq) revealed that
heme induces H3K27ac accumulation at distinct genomic regions
as well as in common regions with β-glucan, a prototypical
inducer of trained immunity (Fig. 1 D–F and SI Appendix, Fig. S2
A–D and Datasets S1 and S2). The vast majority of heme-
induced H3K27ac loci were within 500 kb from a gene promoter,
with 122 occurring in promoter regions (SI Appendix, Fig. S2E).
The second dimension of a t-distributed stochastic neighbor
embedding analysis separated heme- and β-glucan–trained and
naıve Mφ, indicating treatment-specific H3K27ac patterns (Fig.
1D). Further Gene Ontology (GO) analysis reveals that heme
exposure induced H3K27ac at genes involved in wounding and
stress. In contrast, H3K27ac levels at genes related to adaptive
immune regulation were not induced by heme (SI Appendix,
Fig. S2F).
As H3K27ac is associated with transcriptional activation, we
performed bulk RNA sequencing (RNA-seq) to compare the
transcriptional response of human monocytes and Mφ at differ-
ent time points after exposure to heme or β-glucan (Fig. 1 G
and H and SI Appendix, Fig. S3). The largest number of differ-
entially expressed genes occurred at 24 h after stimulation, with
201 genes commonly induced by heme and β-glucan, 140
induced by heme only, and 346 by β-glucan only (Fig. 1G and
SI Appendix, Fig. S3A and Datasets S3–S5). The common signa-
ture is related to lysosome maturation and metabolism, critical
processes required for increased cytokine production in the
context of trained Mφ (25, 26). Pathway analysis using Genomic
Regions Enrichment of Annotations Tool demonstrated that
genes induced by heme are mainly involved in inflammatory
pathways and up-regulated cytokine signaling and stress
responses (Fig.1 G and H). However, heme-induced trained
immunity was not associated with Mφ polarization into classical
M1, M2 (27), or hemorrhage-associated Mφ (M-hem) (28) (SI
Appendix, Fig. S3 B–D). The expression of selected genes
encoding transcription factors with enriched motifs at gene
promoters of heme-induced genes are shown in SI Appendix,
Fig. S3E.
Consistent with increased H3K27ac, expression of GDF15, a
transcription factor involved in the host response to infection
(29), the interleukin (IL) 8 gene, and the heme-degrading gene
HMOX1 were increased (Fig. 1I). Heme also induced transcrip-
tion of heme/iron-related genes FTH1 and HRG1 but not the
iron exporter FPN1 (Fig. 1I and SI Appendix, Fig. S3F). Collec-
tively, heme-induced adaptations in human monocytes are asso-
ciated with a trained innate immune phenotype.
Heme Training Is Mediated via a Spleen Tyrosine Kinase/c-Jun
N-Terminal Kinase–Dependent Pathway. In previous reports,
β-glucan–induced trained immunity relied on the activation
of the mTOR pathway (30). Although in our settings, heme
exposure was also associated with increased phosphorylation
of the mTOR target S6 in monocytes (Fig. 2A), mTOR inhi-
bition by rapamycin did not compromise heme training as
assessed by TNF secretion (Fig. 2B). Previously, it was shown
that heme can signal via a distinct pathway involving the
spleen tyrosine kinase (SYK) (8). We can confirm that heme
exposure induces SYK phosphorylation in human monocytes
(Fig. 2C). Moreover, SYK inhibition by R406 during heme
treatment abolished the heme-training phenotype (Fig. 2 D
and E) and also reduced the global increase in H3K27ac
(Fig. 2F). ChIP-qPCR analysis of the IL8 promoter revealed
elevated histone acetylation that was prevented by R406,
pointing toward an association of heme-induced SYK activa-
tion and H3K27ac (Fig. 2G). In line with the notion that
c-Jun N-terminal kinases (JNK) can act downstream of SYK
activation (31), we show that heme increased JNK phosphor-
ylation in human monocytes (Fig. 2H), an effect that is abol-
ished by SYK inhibition (Fig. 2I). In addition, application of
the JNK inhibitor SP600125 prevented the development of
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heme training (Fig. 2 J and K), supporting the notion that
heme signals via SYK and upstream of JNK to induce trained
immunity.
Heme Induces Resistance to Bacterial Sepsis and Promotes
Myelopoiesis. So far, we have provided experimental evidence
that heme can induce what is referred to as “peripheral”
trained immunity. Long-term effects would be expected only if
immune function–altering modifications would also be
imprinted in self-renewing cells such as bone marrow HSPCs
and potentially affect HSPC expansion and composition (32).
In order to investigate whether also “central” trained immunity
is induced, C57BL/6 mice were trained by heme or vehicle. An
injection of heme at 2 mg/kg did not change the vigor or behav-
ior of the animals (SI Appendix, Fig. S4 A and B). In a first
step, bone marrow cells from vehicle- or heme-trained mice
were isolated 7 d after heme treatment, differentiated into mac-
rophages and exposed to LPS. Heme-trained cells displayed
increased cytokine release after LPS stimulation and enhanced
phagocytosis (Fig. 3 A and B). Heme training was also associ-
ated with enhanced peritoneal recruitment of phagocytic cells,
monocytes, and neutrophils in response to intraperitoneal (i.p.)
LPS administration (Fig. 3 C and D) and increased mortality
(SI Appendix, Fig. S4C). The deleterious effects of heme train-
ing on subsequent LPS-induced systemic inflammation were
also observed in Rag2-deficient mice (Rag2/) lacking mature
B and T cells (SI Appendix, Fig. S4 D and E). This supports the
notion that long-term heme-induced effects on immune
responses are not mediated by cells of the adaptive immune
system. Next, we assessed the host response to infection
Fig. 1. Heme imposes trained immunity and evokes a specific transcriptional signature. (A) Experimental setup. (B) Cytokine release from vehicle- or
heme-trained (50 μM) Mφ after LPS restimulation (10 ng/mL) at day 7, measured with LegendPlex. IL-8 measurement by enzyme-linked immunosorbent
assay. n = 16 independent donors. (C) TNF release from vehicle- or heme-pretreated Mφ second hit at day 7 with Pam3CSK4. n = 6 independent donors.
(D) t-distributed stochastic neighbor embedding (t-SNE) plot of dynamic acetylation peaks in monocytes and vehicle, heme, or β-glucan Mφ 24 h after
stimulation. Dim1: differentiation processes. Dim2: variation because of treatment. (E) Genes with highest number of differential H3K27ac peaks within
1 Mb of their TSS. (F) Representative gene loci. (G–I) Transcriptional analysis by RNA-seq. (G) Heatmap of regulated genes at baseline (t0) and at indicated
time points after heme or β-glucan exposure. GO terms are listed next to each group of genes. (H) Most abundant pathways based on gene expression
analysis 24 h after treatment. White numbers indicate the number of affected genes. (I) Time-resolved expression patterns of genes found with increased
H3K27ac. All analyses were performed from n = 5 individual donors. All data mean 6 SD unless otherwise stated. Student’s t test, *P ≤ 0.05; **P ≤ 0.01.
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subsequent to heme training. A total of 7 or 28 d after i.p.
injection of heme (2 mg/kg) or vehicle, mice were subjected to
polymicrobial sepsis (Fig. 3E) (7). Heme training proved to be
protective in polymicrobial sepsis as illustrated by faster weight
recovery, thermoregulation maintenance, and lower incidence
of mortality (Fig. 3F and SI Appendix, Fig. S4 F and G) when
induced 7 d after heme training. Of note, this protective effect
was associated with a marked reduction in host–pathogen load
(Fig. 3G). Markers of tissue damage as well as serum iron lev-
els were significantly reduced (Fig. 3H). However, when ani-
mals were subjected to polymicrobial sepsis 28 d after heme
training, no survival benefit was observed. Instead, heme-
trained animals had a tendency of increased mortality (SI
Appendix, Fig. S4H).
Our findings suggest that while labile heme can, in principle,
promote resistance to infection (short term) as a trade-off, it
counteracts the establishment of disease tolerance to bacterial
infection presumably by exacerbating the innate immune reac-
tion to bacterial components, such as LPS or as a long-term
consequence.
Based on these findings, we postulated that heme elicits
alterations in hematopoiesis, similar to previous reports of
other trained immunity-inducing agents (17, 33, 34). We
analyzed mouse bone marrow 7 and 28 d after heme or vehicle
treatment. After 7 d, we did not find a difference in cell num-
ber or percentages of LSK cells (LincKit+Sca1+), long-term
hematopoetic stem cells (LT-HSCs, CD48CD150+LSK), or
multipotent progenitors (MPP, CD48+CD150LSK) (Fig. 3 I
and J and SI Appendix, Fig. S5 A–C) as compared to vehicle-
treated mice. However, we observed an increased frequency of
myeloid-biased LT-HSCs (CD41+LT-HSC) (35) as well as of
myeloid-biased MPP3 cells (Flt3CD48+CD150LSK) at the
expense of lymphoid-biased MPP4 cells (Flt3+CD48+CD150
LSK) (36) (Fig. 3 I and J and SI Appendix, Fig. S5 A–C).
Myeloid-biased LT-HSCs (CD41+ LT-HSC) and MPP3 expan-
sion was sustained as far as 28 d after heme administration (SI
Appendix, Fig. S5D). Furthermore, a significant increase in
mature neutrophils and monocyte was observed at this time
point in the bone marrow (SI Appendix, Fig. S5E).
Heme Changes the Epigenetic Landscapes of HSPCs. Given the
long-term cellular and functional adaptations (Figs. 1–3), we
explored whether heme causes changes in the chromatin land-
scape of HSPCs and assessed genome-wide chromatin accessibil-
ity using single nucleus assay for transposase-accessible chromatin
using sequencing (snATAC-seq) on fluorescence-activated cell
Fig. 2. Heme training relies on Syk/JNK activation in human monocytes. (A) Western blot of p-S6 24 h after heme 6 rapamycin stimulation. (B) TNF pro-
duction after restimulation with LPS at day 7 of vehicle- or heme-trained Mφ 6 rapamycin. The representative Western blots of at least three indepen-
dent donors are pictured. (C) Western blot of Syk phosphorylation after heme treatment of human monocytes at indicated time points. (D) Syk phosphor-
ylation 20 min after heme stimulation 6 the Syk inhibitor R406. (E) TNF production after restimulation with LPS at day 7 of vehicle- or heme-trained
Mφ 6 R406. (F) Western blot of total H3K27ac 24 h after heme treatment 6 R406. (G) ChIP-qPCR analysis of H3K27ac at the IL8 promoter (n = 3 indepen-
dent donors). (H) Western blot of JNK phosphorylation after heme treatment of human monocytes at indicated time points. (I) Western blot of JNK
phosphorylation 20 min after heme stimulation 6 R406. (J) Western blot and densitometry of JNK activation 20 min after heme stimulation 6 the JNK
inhibitor SP600125. (K) TNF production after restimulation with LPS at day 7 of vehicle- or heme-trained Mφ 6 SP600125. All enzyme-linked immunosorbent
assay results derived ≥3 independent experiment a 2 to 3 donors; Two-way ANOVA with Fisher’s LSD; mean 6 SEM, *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001;
****P ≤ 0.0001. GAPDH, glyceraldehyde 3-phosphate dehydrogenase; H3, histone 3; H3K27ac, histone 3 lysine 27 acetylation; JNK-I, JNK inhibitor SP600125.
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sorting (FACS)-sorted LSK cells 7 or 28 d after a single dose of
heme and from control animals (Fig. 4 and SI Appendix, Fig. S6).
Using iterative latent semantic indexing (LSI) clustering (37), we
identified 10 cell populations, including an HSC/MPP cloud of
cells, megakaryocyte–erythroid progenitors (MEP), granulocyte–
macrophage progenitors (GMP), and several early committed
immune progenitor cells. Strikingly, the clustering revealed
changes in chromatin accessibility in the cloud of LSK cells that
were subtle at day 7 but became very prominent on day 28 after
heme administration as compared to control (Fig. 4A).
Fig. 3. Persistent heme effects in vivo. (A) Cytokine release of bone marrow–derived macrophages (BMDM), bone marrow (BM) isolated at day 7 after con-
trol (Ctrl; n = 8) or heme (n = 8) injection and 24 h after LPS (10 ng/mL) stimulation. Pool of two independent experiments. (B) Phagocytic capacity of BMDM,
BM isolated at day 7 after Ctrl (n = 4) or heme (n = 4) injection and 2 h after pHrodo Red E. coli stimulation. Pool of two independent experiments. (C) Gating
of myeloid cells. Neutrophils are CD11b+Ly6G+ and monocytes are CD11b+Ly6G– and further distinguished as Ly6Chigh (inflammatory monocytes) and
Ly6Clow (patrolling monocytes). Peritoneal Mφ were gated as CD11bhighLy6G–F4/80+. (D) Cell count and flow cytometry analysis of peritoneal lavage fluid of
vehicle- or heme-pretreated mice at day 7 and 6 h after endotoxemia. (E) Experimental setup. (F) Survival of polymicrobial sepsis induced 7 d after vehicle
(n = 10) or heme (n = 10) treatment in mice. Pool of two independent experiments. Survival: Fisher’s exact test. (G) Pathogen load and (H) serology of vehi-
cle- (n = 8) or heme- (n = 7) pretreated mice 24 h after sepsis induction. Pool of two independent experiments. Mann–Whitney U test; mean, *P ≤ 0.05; **P ≤
0.01; ***P ≤ 0.001. (I) Experimental setup. (J) Flow cytometry analysis of indicated HSPC cellular subsets of vehicle- or heme-pretreated mice at day 7. n = 5
to 6 animals per group derived from two independent experiments. Student’s t test; mean6 SD, *P ≤ 0.05; **P ≤ 0.01. Ae, aerob; ALT, alanin aminotransfer-
ase; An, anaerob; h, hours; hi, high; IFN, interferon; IL, interleukin; LDH, lactate dehydrogenase; LSK, LinSca1+cKit+; Neutrop, neurophils; n.s., non-signifi-
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Fig. 4. Single-cell epigenetic landscape of heme-trained HSPCs in mice. (A) UMAP projection of 4,842 (Control), 5,562 (Heme 7d), and 6,052 (Heme 28d)
single-nuclei (sn) ATAC profiles from sorted bone marrow–derived LSK cells. Each dot represents an individual cell, and colors represent the identity of
the cluster. An annotation of the clusters was performed according to the overlay of epigenetic signatures (ImmGen Database) and known marker genes
per cell type. (B) Enrichment of epigenomic ImmGen Database signatures (area under the curve [AUC] scores) of the HSPCs onto UMAP projection of LSK
cells. (C) Pseudotime trajectory of pGN differentiation and heme-trained cells from ST-HSCs in control LSK cells and after 28 d of heme training, respec-
tively. (D) TF footprint analysis in the indicated snATAC-seq clusters of non- and heme-treated LSK cells subtracted for Tn5 insertion bias shown below.
(E) TF motif scores from bone marrow cells projected onto the UMAP. (F) UMAP projection colored by log-normalized gene scores calculated on the indi-
vidual LSK cell types. (G) Enhancer–promoter connections (coaccessibility) of the Nfix locus in control- and heme-trained cells. The height of connections
indicates the coaccessibility score between the connected peaks. Ctrl, control; pGN, precursor of granulocytes; pDC, precursor of dendritic cells; pNK, pre-
cursor of NK cells; pLB, precursor of B lymphocytes; NC, normalized count.
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We classified these shifted HSPC populations as short-term
(ST) HSC (STHSC.150-.BM) and the MPP3 biased as “heme-
trained” cells (MPP3.48+.BM) (Fig. 4 A and B and SI Appendix,
Fig. S6 A and B). Early committed cell subpopulations (e.g.,
MEP, GMP) were sharply decreased at day 28. Interestingly, the
number of long-term HSCs (LTHSC.34-.BM) also diminished
after heme administration (Fig. 4A and SI Appendix, Fig. S6A).
Long-Lasting Alteration of Chromatin Sustains Access for
Transcription Factors Promoting Myelopoiesis. To gain further
molecular insight, we arranged the cells on a pseudotime devel-
opment trajectory (37). In control bone marrow, the myeloid
differentiation path (38) from HSC to progranulocytes (indi-
cated by the dark blue and yellow circle, respectively) is
evident. Heme application caused a prominent shift in the tra-
jectory, now leading toward the novel heme-trained population
(Fig. 4C). To assess factors that direct these different pathways
and characterized the epigenetic landscape of de novo heme-
trained cells, we performed motif enrichment and transcription
factor (TF) footprinting analyses of chromatin-accessible
regions (39). The binding sites of Runx1, a TF well known for
its role in sustaining the stemness of hematopoietic cells (40),
ranked highest, thus validating our approach (Fig. 4 D and E
and SI Appendix, Fig. S6C). Next in line is the CCAAT-box, the
binding site of nuclear factor I (Nfi) family members that form
homo- and heterodimers. Importantly, the relative distribution
of the motifs was drastically altered from LT-HSC in control
bone marrow to ST-HSCs and heme-treated MPP3-biased cells
upon heme treatment correlating with the altered trajectory
(Fig. 4E). The motif analysis also included Nfe2l2, a vital regu-
lator of the oxidative stress response and HSC homeostasis
(41) (Fig. 4D and SI Appendix, Fig. S6C). Gata2, the master
regulator of the MEP lineage, was prominently detected in con-
trol and, to a lesser extent, in the bone marrow of heme-treated
mice (Fig. 4D). The projection of the TF motif deviation scores
onto the Uniform Manifold Approximation and Projection
(UMAP) plots visualizes the notable shifts in the abundance
and cell-specific occurrences of the TF-binding motifs in con-
trol versus heme LSK cells (Fig. 4E). The Runx1 motif was
abundant in the MPP3/4 population in control and shifted
toward the heme-trained cell population, whereas the Nfi motif
shifted from the LT-HSC to the ST-HSC and heme-induced
MPP3-biased cells. Thus, the persistence of stemness-associated
TFs (Runx, Nfi, Spi, and Elf TF families) characterizes the heme-
trained population.
The Runx1 and Nfi-binding motifs do not unequivocally
point to the relevant TFs, as several closely related family mem-
bers bind to the same or very similar motif. Therefore, we
inferred the gene expression level (activity score) based on the
accessibility of cis-regulatory elements in the proximity of can-
didate TFs (42) and projected the scores onto the UMAP clus-
tering. The Nuclear Factor One X (Nfix) is the most likely
family member to bind to the Nfi motif and regulate the skewed
myelopoiesis. At first, the inferred Nfix activity correlates well
with the rerouting of the differentiation trajectory from
LT-HSC to ST-HSC/heme-trained cluster (Fig. 4F). Secondly,
the gene activity score of the Nfib does not follow the altered
trajectory, although it seems to play a yet to be discovered role
in the HSPC, whereas Nfia and -c appears to play a role in
MEPs. Thirdly, Nfix has been implicated in stem cell survival
and the regulation of lineage specification toward myeloid cells
(43–45) (Fig. 4D and SI Appendix, Fig. S6 C and D).
Heme has recently been reported to inhibit the BTB domain
and CNC homolog (Bach) TFs, impeding erythroid commit-
ment and favoring myelopoiesis (46). Our chromatin accessibil-
ity analysis shows scattered gene activity as well as motif
deviation scores throughout HSCs and early committed
myeloid cells but is enriched and more restricted in the
heme-trained population compared with control (Fig. 4 E and
F). Interestingly, HOMER motif analysis revealed several
Bach2-binding sites at the Nfix locus, suggesting a potential reg-
ulatory axis between Bach2 and Nfix (Dataset S6). In support
of this, heme-trained ST-HSC show time- and treatment-
specific accessibility differences at the Mpl and Erg genes (SI
Appendix, Fig. S6E), potential downstream regulators of mye-
loid lineage commitment and survival. Finally, GO enrichment
analysis unveiled enrichment in biological processes linked to
positive regulation of leukocyte and myeloid cell differentiation
and negative regulation of megakaryocyte differentiation in
the HSC/heme-trained population, supporting our findings (SI
Appendix, Fig. S6F).
Thus, we uncover heme-mediated, long-lasting modifications
of the chromatin-accessible landscape that favors myelopoiesis,
reminiscent of innate immune training.
Discussion
Trained immunity is a fundamental feature of myeloid cells
allowing innate immune cells to respond to rechallenge by the
same or an unrelated pathogen in a more efficient manner
(18–20, 25, 47). Our data show that extracellular labile heme
acts as a potent inducer of trained immunity. In contrast to pre-
vious reports, heme training involves a SYK/JNK phosphoryla-
tion signal transduction pathway (18–20, 25, 47). How heme
induces SYK phosphorylation, independently of TLR4 and JNK
signaling–linked histone modifications, remains to be deter-
mined. However, it is conceivable that there is no specific heme
receptor involved, as SYK activation can occur via autophos-
phorylation (48), which could be triggered by heme–membrane
interaction. It is also unclear to this point how JNK signaling
leads to epigenetic modifications and which cofactors are being
involved.
Heme possesses a highly redox-active central iron atom, con-
ferring its strong pro-oxidant properties (1). Heme training,
however, appears not to rely on this redox activity, as we can
show that both scavenging reactive oxygen species (ROS) as
well as PPIX and several other metal-containing porphyrins
also induces innate immune training in vitro. The reason for
this remains to be revealed. It is conceivable that the porphyrin
ring itself can induce a yet to be established signal transduction
and biological function that acts independently of its iron core.
In fact, PPIX activates JNK phosphorylation (49), suggesting
that the same pathways are activated as by heme. This notion is
supported by our finding that ROS were not increased after
heme training and that the application of the antioxidant NAC
did not abolish heme-induced training as would be expected if
a redox-sensitive mechanism was involved (49). A less likely
explanation would be that porphyrins undergo noncatalytic
metalation or transmetalation that are at least in principle pos-
sible (50, 51), replacing the central metal by iron.
Our data specifically links heme training to IL8 biology, a
chemokine especially involved in the recruitment and degranu-
lation of innate immune cells. We report increased IL8 secre-
tion and RNA expression and reveal that IL8 is the gene with
the highest number of differential H3K27 acetylation peaks in
proximity of the transcription start site. In contrast to the heme-
induced IL8 modifications, no histone modification of IL8 was
detected after β-glucan exposure. IL8 expression is regulated by
histone acetylation (52, 53), which indicates that H3K27ac in the
IL8 promotor leads to an increased IL8 chemokine production
of heme-pretreated cells in response to LPS. Blocking histone
deacetylases increases the transcription of IL8. On the other
hand, the suppression of CREB-binding protein, exerting a his-
tone acetyltransferase activity, blocked IL8 expression (53). This
was dependent on increased ability of the p65 unit of NFκB to
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(53). It is also well known that LPS induces NFκB in a TLR4-
dependent manner (54). It follows that histone acetylation in the
IL8 promotor region might enhance the binding capacity of the
p65 NFκB, activated through the LPS signaling and subsequent
enhanced IL8 release.
Despite increased TNF secretion in heme-trained Mφ, we
could not find a difference in H3K27ac levels at the TNF pro-
moter after heme treatment when compared to control cells,
which is in line with the pan-innate immune training signature
observed in both heme- and β-glucan–exposed Mφ that involves
the up-regulation of mechanisms resulting in cytokine release
but not cytokine gene priming. This is also in agreement with
recent findings by other authors who used a model of IFN-γ
priming (55). Increased TNF production was also unrelated to
H3K27ac in the TNF promotor itself, as IFN-γ–dependent
modifications occur at a region 8 kb upstream of the TNF pro-
motor (55). Additionally, trained immunity does not only
depend on H3K27ac but also on histone methylation (20, 56).
This has been exemplarily shown for activating the activating
H3K4me3 mark at promotor regions and the H3K4me1 mark
at enhancers in β-glucan–trained Mφ (57). These marks were
not part of our investigation.
We also assessed the recently identified heme-responsive
motifs (HERM) (58, 59). However, none of the motifs were
located in the genes of interest. In addition, analyzing a region
of 200 base pairs (bp) upstream and 200 bp downstream of the
HERM element, there were only two heme peaks overlapping
out of 450 induced by heme. This suggests that HERM motifs
might not be relevant for heme-induced trained immunity.
Innate immune training is generally considered a beneficial
adaptive long-term phenomenon that improves disease severity
and survival of subsequent infections (19, 20, 30, 60). However,
evidence for maladaptive responses, that is, nonprotective
trained immunity, has been shown in models of chronic sus-
tained inflammation such as atherosclerosis and Mycobacterium
tuberculosis infection. When monocytes were exposed to oxi-
dized low-density lipoprotein (oxLDL), these exhibited an
increased inflammatory response and enhanced foam cell for-
mation, a hallmark of atherosclerosis progression (61, 62). In
vivo, a Western type, high-fat diet given to Ldlr/ mice, a clas-
sical model for atherosclerosis, induced trained immunity (63).
The recently published study by Khan et al. provides evidence
that in contrast to the vaccine strain Bacillus Calmette–Guerin
(bacillus Calmette–Guerin), Mycobacterium tuberculosis does
not induce but rather impairs innate immune training (64).
We here provide evidence that heme can induce both protec-
tive (i.e., early bacterial sepsis) and deleterious (i.e., endotoxic
shock or delayed bacterial sepsis) trained immunity. This is the
first demonstration, that the same stimulus has opposing effects
depending on the context and timing. In principle, the deleteri-
ous innate immune training could manifest at a peripheral
level, for example, via enhanced cytokine release and associated
tissue damage (65), exceeding the benefits of decreased patho-
gen loads and at a central level, for example, via maladaptive
myelopoiesis, impairing the host response to infection. In bene-
ficial innate immune training, this would manifest at a periph-
eral level as improved resistance to infection and at the central
level as enhanced myelopoiesis supporting pathogen destruc-
tion and tissue repair. For heme-induced training, we postulate
that maladaptive effects in the LPS model are indeed caused by
enhanced tissue damage while no beneficial effects of pathogen
destruction can occur since this is a sterile inflammation. Con-
versely, in sepsis, the protective effect of heme training was
directly associated with a significant enhanced resistance to
infection, that is, decreased pathogen loads. Whether heme-
induced training results in heterologous protective immunity
(66) against infections by other classes of pathogens or whether
it will exert immunopathology to chronic inflammatory disease
needs to be further investigated.
It is widely assumed that innate immune memory is encoded
in the epigenome. However, the proof in vivo has been scarce so
far (57). We document striking, long-term changes in cellular,
transcriptional, and chromatin accessibility 28 d following a one-
time exposure to heme, which did not affect the animals’ vigor.
This prominent response to heme manifests as the expansion of
ST-HSC–like cells and the appearance of a heme-trained cell
population. Chromatin footprinting and motif analysis revealed
drastic changes in the binding sites of TF Nfix along with the
well-known Runx1, Nfe2l2, and Bach2. A plausible scenario
linking the reported down-regulation of Bach1/2 repressor TFs
(46) by heme with our observed long-term alterations of the
chromatin-accessible regions of heme-trained HSPCs favors per-
sistence of myeloid differentiation and stemness-related genes.
Our data also suggest that hosts exposed to labile heme, as it
would occur in malaria, bacterial sepsis, or other form of hemoly-
sis, will likely prime hematopoietic stem cells toward adapted
myelopoiesis. Whether this striking long-term modulation of the
hematopoiesis is responsible for the maladaptive response to sep-
sis 28 d after heme training remains to be established.
Generally, several open questions remain and will be tested
experimentally in the future, for example, how long does heme
training last? Can the training signature be reversed by heme
training as has been shown for β-glucan (26)? Does heme training
confer protection to other, also noncommunicable disease, and if
so, how would this be explained evolutionarily? Is heme the train-
ing mediator, or does heme application result in the release of
cytokines or other molecules that induce innate immune training,
and if so, is this a universal feature or trainer specific?
In conclusion, we here reveal that heme, a bona fide alarmin,
induces peripheral as well as central innate immune memory
regulating host response to infection. Previously reported
trained immunity inducers are, however, infrequently present
in the host, whereas heme abundantly occurs during noninfec-
tious and infectious disease. Hence, we propose that trained
immunity is an integral component of innate immunity to con-
fer long-term host protection.
Materials and Methods
Preparation of Pooled Human Serum. All procedures were approved by the
Ethics Committee of the University Hospital Jena, license reference 4899–07/
16. Blood was collected from healthy volunteers into a S-Monovette
(Sarstedt), and serum was collected according to manufactures instructions.
Serum was pooled and centrifuged, sterile filtrated, and stored at 80 °C
until usage.
Isolation of Peripheral Blood Mononuclear Cells and Human Monocytes.
Peripheral blood mononuclear cells were isolated from buffy coats that were
obtained from the Institute of Transfusion Medicine, Jena University Hospital,
or from blood freshly donated by volunteers (ethical approval of the Ethics
Committee of the Jena University Hospital, license reference 4899–07/16).
Isolation was performed as previously described (24).
Isolation of Murine Bone Marrow Cells. Bone marrow was isolated from fem-
ora and tibiae of male 8- to 12-wk-old C57BL/6J mice. Bones were flushedwith
Roswell Park Memorial Institute medium (RPMI) containing 10% fetal calf
serum (FCS) and 1% Pen/Strep and stable glutamine. Cells were centrifuged at
4 °C (7 min; 350 g). Erythrocytes were lysed by resuspending the pellet in red
blood cell lysis buffer (150 mM NH4Cl; 10 mM KHCO3; 130 μM ethylenedi-
aminetetraacetic acid (EDTA)). The reaction was stopped by adding RPMI and
cells were again centrifuged thereafter. Cells were used directly or stored at
150°C as cryogenic stock.
Differentiation of Murine Bone Marrow–Derived Macrophages. Cells from
murine bone marrow were cultured in RPMI containing 10% FCS and 1%
Pen/Strep. Differentiation was induced by adding 20 ng/mL
granulocyte–macrophage colony-stimulating factor (GM-CSF; Peprotech).
After 1 wk, cells were harvested and seeded on well plates and incubated for
8 of 10 j PNAS Jentho et al.
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1 dwith GM-CSF (20 ng/mL; Peprotech). Training experiments were performed
with these cells according to the monocyte training protocol. During this time,
0.2 ng/mL GM-CSFwas always added to the medium. For the determination of
cytokine levels released from bone marrow macrophages of vehicle- or
heme-trained mice, cells were restimulated with LPS. Cytokines were mea-
sured 24 h after stimulation.
Monocyte Training. Monocyte training was adapted from Bekkering et al.
(24). To initiate training, cells were either incubated with culture medium
(RPMI 1640 Dutch modification supplemented with 10% pooled human
serum, 2 mM GlutaMAX, and 1 mM pyruvate and 10 μg/mL gentamicin) as a
negative control or with the respective stimuli for 24 h. For inhibition experi-
ments, cells were incubated with the respective inhibitor 1 h prior to stimula-
tion and throughout the 24 h of stimulation. After 24 h, cells were washed,
and new culture medium with serum was added to the cells. On day 6, cells
were stimulated with 10 ng/mL LPS in culture medium. Supernatants were col-
lected 24 h later, and cytokine levels were determined. Cells were either lysed
by radioimmunoprecipitation assay buffer (protein analysis) or in Qiazol (tran-
scriptional analysis).
Pharmacological Approaches. Stimulation was performedwith 50 μMheme or
50 μM PPIX (Sigma-Aldrich or Frontier Scientific) and 50 μM of other porphyr-
ins as indicated, unless otherwise stated. All were prepared as described in ref.
2. For β-glucan training, cells were stimulated with 1 μg/mL β1,3-(D)-glucan.
Acetyltransferases were inhibited with EGCG (15 μM; Sigma-Aldrich) (16).
R406 (1 μM; InvivoGen) was used for inhibiting spleen tyrosine kinase
activation. The JNK pathway was blocked by SP600125 (10 μM; InvivoGen).
Rapamycin (10 nM; InvivoGen) was used for blocking mTOR-mediated signal
transduction. ROS were scavenged by N-acetylcystein (10 mM; Fluka). ROS
measurements were performed by incubating the cells with H2DCFDA and
flow cytometry analysis. Ultrapure LPS from Escherichia coli O55:B5 (Cat#:
tlrl-pb5lps) and ATP was purchased from InvivoGen.
Animal Experiments. Experimental procedures were ethically reviewed and
approved by the Ethics Committee of the Instituto Gulbenkian de Ciência
(license reference: A009/2011) by Direç~ao Geral de Alimentaç~ao e Veterinaria
(license reference: 0420/000/000/2012) or for animal experiments at the
Jena University Hospital by the regional animal welfare committee (registra-
tion no.: 02–044/16, Thuringian State Office for Consumer Protection
and Food Safety). All experiments conducted on animals followed the Portu-
guese (Decreto-Lei no. 113/2013) or the German legislation on the protection
of animals and the European legislations (Directive 2010/63/EU) concerning
housing, husbandry, and animal welfare. C57BL/6 mice were bred and
maintained under specific pathogen-free conditions at the Instituto Gulben-
kian de Ciência or at the Jena University Hospital (10/14 h day/night; fed ad
libitum). Rag2/ mice were bred and maintained at the Instituto Gulbenkian
de Ciência, Oeiras, Portugal. Mice received 2 mg/kg body weight (BW)
heme or vehicle (NaOH; pH 7.4) via i.p. injection. For endotoxic shock survival
experiments and flow cytometric analysis of peritoneal lavage fluid cells,
mice received 15 mg/kg LPS (E. coli O55:B5; Sigma-Aldrich) 1 wk after
heme treatment.
Polymicrobial sepsis was induced using a well-characterized, standardized
human stool suspension (peritoneal contamination and infection) (7). Animals
received one i.p. injection of 0.85 μL feces/g BW and 25 μL/g BW sterile 0.9%
NaCl solution. Temperature, weight, and clinical severity were monitored
using an established score system (7).
Quantification and Statistical Analysis. Survival plots were analyzed as indi-
cated. One-way ANOVA with Fisher’s least significant difference (LSD) was
used to analyze more than two groups. Two-way ANOVA with Fisher’s LSD
was used when analyzing more than one group and time point. Student’s t
test was used for pairwise comparisons. For the analysis of the pathogen load,
the Mann–Whitney U test was used due to the high variance of SDs. Floy
cytometry and FACS data analysis was performed using FlowJo (Tree Star) soft-
ware. Mean and SD were used whenever single values were compared. Mean
and SEM were used to compare means of distinct experiments with replicates
within the same experiment and setting.
RNA-seq analysis. To determine gene expression levels, RNA-seq reads were
aligned to the Ensembl v68 human transcriptome using Bowtie 1. The quanti-
fication of gene expression was performed using Many-against-Many
sequence searching (MMSEQ). Differential expression was determined using
DESeq. Differentially expressed genes were determined using pairwise com-
parison between treatments, with a fold change > 2.5, adjusted P value of
< 0.05, and Reads per kilobase of transcript per Million mapped reads
(RPKM) ≥ 5.
ChIP-seq analysis. Sequencing reads were aligned to human genome assem-
bly hg19 (National Center for Biotechnology Information [NCBI] version 37)
using bwa. Duplicate and low-quality reads were removed after alignment
using Samtools and Bamtools. For peak calling, the BAM files were first fil-
tered to remove the reads with a mapping quality less than 15 followed by
fragment size modeling. MACS2 was used to call the peaks. H3K27ac peaks
were called using the default (narrow) setting. Reads/peak tables were
merged using Bedtools. Data were normalized using the R package DESeq1,
and then pairwise comparisons were performed (fold change > 1.5; P value <
0.05 and mean reads/peak ≥ 20 in any condition) to determine the differen-
tial peaks.
snATAC-seq data preprocessing and analysis. Binary base call (BCL) files
were demultiplexed by Cell Ranger ATAC (version 1.1.0) using “cellranger-
atac mkfastq.” FASTQ files were aligned to the mm10 reference genome
using “cellranger-atac count” with default parameters. This pipeline also
marks duplicated reads and identifies transposase cut sites. Cells were filtered,
keeping those with a transcription start site (TSS) enrichment of at least eight
and more than 1,000 unique fragments. This approach allows the detection
of TSSs without having a defined peak set. Since the peak calling was per-
formed separately, peaks do not overlap perfectly and might be treated as
entirely different features. Using the Granges package, we find overlaps of
the chromosome coordinates among samples as previously described (37). The
obtained count matrix was used to generate a union peak set, first binarizing
the top 20,000 most accessible sites followed by term frequency–inverse docu-
ment frequency transformation. We then used singular value decomposition
implementation and created a Seurat (67) (version 3.1.5) object for nonlinear
dimension reduction. LSI scores were then used for clustering, and a visual
representation of the clusters was performed using a UMAP projection. To
annotate the cell clusters and perform GO enrichment analysis, we used the
union peak set and looked for the enrichment of epigenomic signatures, as
well as linking regions to genes, and determined GO terms that are enriched
using CisTopic (version 0.3.0) (68). Bulk ATAC profiles of purified cell types
from the mouse immune system (ImmGen Database) were used as a reference
(38). Additionally, each accessible region was linked to the nearest gene based
on CHIPseeker annotations, and the probability of each region to a defined
set of marker genes (gene activity score) was depicted as the log of normal-
ized counts + 1. To infer the pseudotime trajectory, we aligned and ordered
in the two-dimensional UMAP subspace the single cells across an expected dif-
ferentiation path. The order's significance is obtained after permuting the
trajectory 5,000 times and computing the average rank of the ordering
for the permuted and input trajectory as described elsewhere (37).
Enhancer–promoter connections were detected using Cicero (version 1.3.4.9)
using default parameters (42). Motif enrichment and TF footprinting analyses
and the aggregation of cells from each condition to create a bulk track per
cluster for peak calling and visualization were carried out using ArchR (version
0.9.5) (39). Details of the analyses can be checked at https://www.archrproject.
com. All plots and analyses were performed using R (version 4.0).
For further details, see SI Appendix,Material andMethods.
Data Availability. RNA sequencing and snATAC-seq data have been deposited
in NCBI Gene Expression Omnibus (GSE111003).
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